Identity
- Trade Name
- therascreen® KRAS RGQ PCR Kit FDA UDI
- Generic Name
- KRAS gene mutation IVD, kit, nucleic acid technique (NAT) FDA UDI
- Model / Reference
- 1 FDA UDI
Identifiers
- Catalog Number
- 870021 FDA UDI
- Primary DI / UDI-DI
- 04053228002048 FDA UDI
- FDA Product Code
- OWD FDA UDI
- GMDN Term
- KRAS gene mutation IVD, kit, nucleic acid technique (NAT) FDA UDI
Classification
- Device Class
- Class III FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: KRAS gene mutation IVD, kit, nucleic acid technique (NAT)
therascreen® KRAS RGQ PCR Kit by Qiagen, Inc. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as KRAS gene mutation IVD, kit, nucleic acid technique (NAT).
- cobas® KRAS Mutation Test — Roche Molecular Systems, Inc. · Class III
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class III | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Qiagen, Inc.
Sources (1)
- FDA UDI 0183de6f-edfd-418d-8380-66845fdbd810 33 fields · synced May 31, 2026